Long-term outcomes of immunosuppression - naïve steroid responders following hospitalization for acute severe ulcerative colitis
INTRODUCTION: Acute severe ulcerative colitis (ASUC) is a severe complication of ulcerative colitis (UC) that is associated with significant morbidity, treatment refractoriness and need for colectomy. Patients who do not adequately respond to the initial intravenous steroid therapy receive medical r...
Main Author: | Vedamurthy, Amar |
---|---|
Language: | en_US |
Published: |
2018
|
Subjects: | |
Online Access: | https://hdl.handle.net/2144/27412 |
Similar Items
-
Long-term outcomes of infliximab in a real-world multicenter cohort of patients with acute severe ulcerative colitis
by: Shin Ju Oh, et al.
Published: (2021-07-01) -
Has infliximab influenced the course and prognosis of acute severe ulcerative colitis?
by: Viscido A, et al.
Published: (2019-04-01) -
Comparable Long-Term Outcomes of Cyclosporine and Infliximab in Patients With Steroid-Refractory Acute Severe Ulcerative Colitis: A Meta-Analysis
by: Kata Szemes, et al.
Published: (2020-01-01) -
Long-term results of medical treatment in patients with a severe attack of ulcerative colitis
by: I L Khalif, et al.
Published: (2015-02-01) -
The efficacy and safety of infliximab and calcineurin inhibitors in steroid-refractory UC patients: A meta-analysis
by: Heng-Nan Zhao, et al.
Published: (2021-01-01)